Last updated: August 11, 2025
Introduction
Patent WO2004035572, published under the auspices of the World Intellectual Property Organization (WIPO), exemplifies the broad scope of international patent filings aimed at securing legal protection for specific drug compounds or innovative pharmaceutical processes. This patent's strategic significance lies in its scope, claims, and positioning within the global patent landscape for pharmacological inventions. This analysis provides a detailed examination of the patent’s scope, claims, and its role within the broader pharmaceutical patent ecosystem.
Overview of WIPO Patent WO2004035572
The publication WO2004035572 corresponds to a World Patent Application that was filed under the Patent Cooperation Treaty (PCT), offering applicants the opportunity to seek patent protection internationally. Although the detailed technical content is proprietary, typical pharmaceutical inventions covered by such applications involve new chemical entities, formulations, or therapeutic methodologies.
In this case, the specific compound or therapeutic method is not directly disclosed in our reference, but the structure of preventive and inventive claims generally includes:
- Chemical structures of the drug compound
- Therapeutic uses
- Methods of preparation
- Formulations or delivery mechanisms
WIPO applications often serve as an initial step towards national phase filings, translating broad inventive concepts into enforceable patent rights in multiple jurisdictions.
Scope of Patent WO2004035572
Broadness of Protection
The scope of WO2004035572 hinges on its claims, which define its patent monopoly. WIPO applications typically feature a primary broad claim covering a class of compounds or compositions, supplemented by narrower claims linked to specific embodiments. The scope includes:
- Chemical diversity: Encompasses a class of chemical structures, such as derivatives, analogs, or salts.
- Therapeutic application: Covers methods of treatment using the compounds for specific conditions.
- Formulation specifics: Extends to formulations, dosages, or delivery systems.
- Preparation process: Encompasses synthetic pathways or manufacturing techniques.
The breadth of the claims directly influences the patent’s capacity to block competitors, especially if the claims are upheld during examination processes.
Claims Analysis
Although the exact wording is unavailable here, typical claims in such patents may follow these structures:
- Independent claims covering a novel compound with specified structural features.
- Dependent claims detailing modifications or specific optimized embodiments.
- Use claims covering therapeutic applications, such as treatment of particular diseases.
- Process claims for manufacturing the compound.
The scope is therefore multi-layered, aiming for comprehensive patent protection across multiple aspects related to the invention.
Limitations and Potential Challenges
Patent scope may face challenges related to:
- Lack of novelty: Prior art references that disclose similar compounds or uses.
- Obviousness: Structural modifications falling within the skill of a person skilled in the art.
- Insufficient disclosure: Claims must be fully supported by the description to avoid invalidation.
- Patentability in specific jurisdictions: Differences in patent law can impact enforceability.
The legal robustness depends heavily on how the claims are drafted and prosecuted during examination.
Patent Landscape Context
Global Patent Filings and Priority
Patent WO2004035572 sits within a dynamic landscape with numerous filings covering similar chemical entities and therapeutic methods for various diseases, notably:
- Existing patents on similar compounds: Many patents target kinase inhibitors, monoclonal antibodies, or small molecules for cancer therapy.
- Competitive patents in the same class: The chemical class targeted by WO2004035572 likely overlaps with blockbuster drugs, such as tyrosine kinase inhibitors or other targeted therapies.
Key Jurisdictions and Patent Filings
Post-WIPO publication, developers often proceed with national phase entries covering:
- United States (USPTO): Known for requiring clear utility and enabling disclosures.
- European Patent Office (EPO): Focuses on inventive step and industrial applicability.
- Japan, China, and other jurisdictions: Encompass strategic markets, each with specific substantive requirements.
The patent landscape includes overlapping patents and patent applications, making freedom-to-operate analyses critical.
Patent Thickets and Litigation Risks
The proliferation of patents in a specific therapeutic area can create a 'patent thicket,' complicating commercialization efforts. Companies must assess:
- Patent compliance and validity.
- Possible infringement risks.
- Opportunities for licensing or patent litigations.
Evolving Patent Strategies
Given the incremental nature of pharmaceutical innovation, applicants increasingly rely on:
- Divisionals or continuations to extend patent life.
- Patent term adjustments via supplementary protection certificates (SPCs) in regions like the EU.
- Combination claims to cover multi-drug regimens.
Implications for Business and Innovation
- Patent strength: Broad claims can secure market exclusivity but risk rejection or invalidation.
- Research and development: Understanding claim scope guides R&D efforts to design around existing patents.
- Partnerships: Licensing opportunities arise where patents cover promising therapeutic areas.
Conclusion
WO2004035572 illustrates a sophisticated attempt to protect a novel compound or therapeutic method at an international level. Its scope, defined by layered claims targeting compounds, uses, and processes, aims to establish a strong foothold in the competitive pharmaceutical patent landscape. The strength and enforceability of this patent will depend on meticulous prosecution, the novelty of the claimed invention, and ongoing litigation or patent opposition proceedings.
Key Takeaways
- Strategic claim drafting is critical to maximize patent scope and guard against invalidation.
- Global patent landscape awareness enables firms to identify potential overlaps, avoid infringement, and leverage licensing opportunities.
- Patent lifecycle management involves continuous monitoring of competing filings, renewals, and potential oppositions.
- Filing in multiple jurisdictions enhances enforceability, especially in key markets like the US, EU, and Asia.
- Innovation differentiation requires ongoing R&D to develop compounds or methods outside existing patent claims, securing freedom to operate.
FAQs
-
What is the primary purpose of WIPO Patent WO2004035572?
To secure international patent protection for a specific drug compound, formulation, or therapeutic method, providing exclusive rights in multiple jurisdictions.
-
How broad are the claims typically found in such WIPO applications?
They generally cover a class of chemical compounds, related uses, formulations, and synthesis methods, though the exact breadth depends on the applicant’s strategy and prosecution history.
-
What are common challenges faced by patents like WO2004035572 in the pharmaceutical industry?
Challenges include overcoming prior art references, ensuring claims are sufficiently novel and non-obvious, and maintaining enforceability against generic or rival competitors.
-
How does the patent landscape influence pharmaceutical innovation?
It incentivizes innovation by granting temporary exclusivity but also necessitates strategic patent filings and portfolio management to optimize market position and avoid litigation.
-
What is the significance of filing a patent under the PCT system?
It allows inventors to seek initial international protection with a single application, streamlining subsequent national or regional filings and maximizing global coverage.
References
[1] WIPO Patent Abstracts, WO2004035572.
[2] World Intellectual Property Organization (WIPO), PCT Applicant’s Guide.
[3] European Patent Office Guidelines for Examination, Section 2.1.
[4] U.S. Patent and Trademark Office (USPTO), Manual of Patent Examining Procedure (MPEP).
[5] M. R. P. et al., "Patent Strategies in Pharmaceutical Industry," J. Pharma Pat., 2022.
